Screening and validation of type 2 diabetes mellitus related circRNAs

被引：0
|
作者：
王思思 [1 ]
机构：
[1] Sch Public Health, Capital Med Univ
来源：
China Medical Abstracts(Internal Medicine) | 2019年 / 36卷 / 02期
关键词：
Screening and validation of type 2 diabetes mellitus related circRNAs;
D O I：
暂无
中图分类号：
R587.1 [糖尿病];
学科分类号：
摘要：
which were associated with type 2 diabetes mellitus（T2DM） and validate their clinical significance. Methods CircRNAs profiling microarray and bioinformatics methods were performed to detect insulin-signaling-pathway-related circRNAs,including hsa;irc;056891,hsa
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [41] Screening for type 2 diabetes mellitus:: more than looking for undiagnosed diabetes
    González-Clemente, JM
    MEDICINA CLINICA, 2004, 123 (05): : 177 - 180
  • [42] Early experience with the Diabetes Australia type 2 diabetes mellitus screening criteria
    Smit, WJF
    Chiera, V
    Botcher, R
    Cochrane, J
    MEDICAL JOURNAL OF AUSTRALIA, 2000, 172 (12) : 621 - 622
  • [43] Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients
    Yang, Jiayue
    Yang, Cheng
    Shen, Hong
    Wu, Wenjun
    Tian, Zhen
    Xu, Qinghua
    Cao, Cuiping
    Ye, Shugao
    Ban, Le
    Tong, Xin
    Mei, Jie
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [44] Screening of circular RNAs and validation of circANKRD36 associated with inflammation in patients with type 2 diabetes mellitus
    Fang, Yuan
    Wang, Xiaoxia
    Li, Wenqing
    Han, Jingli
    Jin, Junhua
    Su, Fei
    Zhang, Junhua
    Huang, Wei
    Xiao, Fei
    Pan, Qi
    Zou, Lihui
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 (04) : 1865 - 1874
  • [45] Discovery and validation of PZP as a novel serum biomarker for screening lung adenocarcinoma in type 2 diabetes mellitus patients
    Jiayue Yang
    Cheng Yang
    Hong Shen
    Wenjun Wu
    Zhen Tian
    Qinghua Xu
    Cuiping Cao
    Shugao Ye
    Le Ban
    Xin Tong
    Jie Mei
    Cancer Cell International, 21
  • [46] Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus
    Kim, Catherine
    Tabaei, Bahman P.
    Burke, Ray
    McEwen, Laura N.
    Lash, Robert W.
    Johnson, Susan L.
    Schwartz, Kendra L.
    Bernstein, Steven J.
    Herman, William H.
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2006, 96 (09) : 1643 - 1648
  • [47] VALIDATION OF SALIVARY GLUCOSE AS A SCREENING TOOL OF DIABETES MELLITUS
    Choudhry, Afreen Arshad
    Kumar, Pradeep
    Prasad, Mahendra
    Mohapatra, Tapan
    Sharma, Preeti
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2022, 60 (03) : 145 - 152
  • [48] The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus
    van der Leeuw, J.
    van Dieren, S.
    Beulens, J. W. J.
    Boeing, H.
    Spijkerman, A. M. W.
    van der Graaf, Y.
    van der A, D. L.
    Noethlings, U.
    Visseren, F. L. J.
    Rutten, G. E. H. M.
    Moons, K. G. M.
    van der Schouw, Y. T.
    Peelen, L. M.
    HEART, 2015, 101 (03) : 222 - 229
  • [49] Identification of insulin signaling pathway-related circulating circRNAs as biomarkers of type 2 diabetes
    Yan, Yu-xiang
    Li, Jia-Jiang-Hui
    Xiao, Huan-Bo
    Dong, Jing
    Chu, Xi
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50
  • [50] Development and Validation of Treatment Adherence Scale for Type 2 Diabetes Mellitus
    Jadav, Vallari
    Rathod, Hetal
    Jadhav, Sudhir
    Mahajan, Anil
    Palal, Deepu
    Borah, Nirankush
    Verma, Prerna
    Johnson, S.
    Sohkhlet, Gracia Anderson
    Nallapu, Sandeep
    JOURNAL OF DIABETOLOGY, 2023, 14 (02) : 78 - 83
12345